Finnrick, an independent testing programme, publishes 189 assays for Oupeptide: 131 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 58 did not. Most recent assay 20 Jul 2026.
Oupeptide operates from US, NY 38954, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/oupeptide.
Oupeptide sells direct to researchers and operates from Hong Kong. It lists 8 products. It also produces and labels to order, so stock sold under other brand names may come from here.
In its own words: “Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy .”
Oupeptide publishes 5 certificates of analysis on its site. The vendor chose which batches to publish, so those results do not tell you what is in the vial you receive. Of the 8 product pages we opened, 2 state ≥99% purity and every one links its own certificate.
Prices run from $50.00 to $310.00 across 8 listed products. Payment is by cryptocurrency, bank transfer, and paypal. Orders ship with DHL, FedEx, and USPS.
Worth knowing before you order: no card payments and no research-use-only notice. Payment is limited to cryptocurrency (BTC) and bank transfer. Neither route carries the chargeback protection a card payment gives you if an order never arrives or arrives wrong.
Site check: 8 products listed; 5 certificates of analysis published; payment by cryptocurrency, bank transfer, paypal; ships via DHL, FedEx, USPS; operates from Hong Kong.
Oupeptide is listed as active. Finnrick Grade C. Finnrick avg score: 6.6/10 across 164 samples (8 products). Mixed quality — some products test well, others below average.
Oupeptide holds independent lab grade C, assigned across 164 graded samples, average score 6.6/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 63 | 48 passed, 15 failed |
| Tirzepatide | 61 | 49 passed, 12 failed |
| GHK-Cu | 15 | 12 passed, 3 failed |
| Tesamorelin | 14 | 4 passed, 10 failed |
| BPC-157 | 10 | 4 passed, 6 failed |
| Ipamorelin | 7 | 5 passed, 2 failed |
| Semaglutide | 6 | 4 passed, 2 failed |
| TB-500 | 5 | 1 passed, 4 failed |
| Cagrilintide | 4 | 2 passed, 2 failed |
| PT-141 | 4 | 2 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | C (164 samples) |
| Average grader score | 6.6/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.3/5 |
|---|---|
| Delivery | 2/5 |
| Customer service | 2.8/5 |
| Packaging | 2.9/5 |
| Ease of purchase | 2.9/5 |
| Payment | 3.7/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
These details were read from Oupeptide's own website on 2026-08-10. Pages consulted:
Oupeptide is listed as active and we hold 189 Finnrick assays (131 passing, 58 failing its purity threshold); 5 certificates of analysis published on its own site; an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 189 assays for Oupeptide: 131 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 58 did not. Most recent assay 20 Jul 2026.
Oupeptide accepts Cryptocurrency, Bank Transfer, PayPal.
Oupeptide ships from Hong Kong and uses DHL and FedEx and USPS.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Oxygen labs Peptides Review, OxygenPharm Peptides Review, P3 Labz Peptides Review.